The U.S. Patent and Trademark Office will be holding its next biotechnology/chemical/pharmaceutical (BCP) customer partnership meeting on October 19, 2016 at the USPTO Headquarters (Alexandria, VA). The agenda for the meeting is as follows:
• Welcoming and Opening Remarks (10:00 - 10:10 am EDT) -- Jerry Lorengo, Director, TC1600, USPTO; Daniel Sullivan, Director, TC1600, USPTO; and Wanda Walker, Director, TC1600, USPTO
• Writing a 35 USC 112(a)-Enablement Rejection for Methods of Treatment with Organic Compounds (10:10 - 11:00 am) -- Bennett Celsa, QAS, TC1600, USPTO; Sreeni Padmanabhan, SPE, TC1600, USPTO
• Claim Interpretation (11:00 - 11:45 am) -- Jeffrey Lundgren, SPE, TC1600, USPTO
• Lunch (11:45 am - 12:55 pm)
• Functional Claiming in the Life Sciences (12:55 - 1:45 pm) -- Joe Mallon, Partner, Knobbe, Martens, Olson & Bear, LLP
• Enhanced Patent Quality Initiative (EPQI) (1:45 - 2:30 pm) -- Andrea Wellington, Senior Advisor, Office of the Deputy Commissioner for Patent Quality, USPTO
• Break (2:30 - 2:40 pm)
• Rule 130 Declarations for First-Inventor-to-File Applications (2:40 - 3:25 pm) -- Kathleen Fonda, Senior Legal Advisor, Office of Patent Legal Administration (OPLA), USPTO
• Special Programs for Patent Prosecution (3:25 - 4:00 pm) -- Fereydoun Sajjadi, SPE, TC1600, USPTO
• Closing Remarks (4:00 - 4:10 pm) – Directors, TC1600, USPTO
Additional information regarding the BCP customer partnership meeting, including registration information for those wishing to attend the meeting or register for online participation, can be found here.
The BCP is on Oct 19th (not Oct 18th). Thanks.
Posted by: SL | October 03, 2016 at 08:55 AM